1.
PARMAR VINENDRA M, GOSWAMI SUNITA S. EFFICACY AND SAFETY OF TENELIGLIPTIN AS ADD-ON THERAPY TO CONVENTIONAL THERAPY IN INDIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Asian J Pharm Clin Res [Internet]. 2019 Dec. 7 [cited 2024 Apr. 26];12(12):116-20. Available from: https://journals.innovareacademics.in/index.php/ajpcr/article/view/35952